Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Structure-activity studies on organoselenium alkylating agents.

S I Kang1, C P Spears

  • 1Department of Medicine, University of Southern California Comprehensive Cancer Center, Los Angeles 90033.

Journal of Pharmaceutical Sciences
|January 1, 1990
PubMed
Summary

Organoselenium compounds show enhanced reactivity compared to sulfur analogs, but longer chains reduce effectiveness. Modifying leaving groups can restore desired reactivity and cytotoxicity for potential antitumor agents.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Purification and Properties of Inulin Fructotransferase (DFA III-producing) from Bacillus sp. snu-7.

Bioscience, biotechnology, and biochemistry·2016
Same author

Role of resistin in the inflammatory response induced by nicotine plus lipopolysaccharide in human periodontal ligament cells in vitro.

Journal of periodontal research·2014
Same author

Involvement of SDF-1 and monocyte chemoattractant protein-1 in hydrogen peroxide-induced extracellular matrix degradation in human dental pulp cells.

International endodontic journal·2013
Same author

Phase I and pharmacologic study of i.v. hydroxyurea infusion given with i.p. 5-fluoro-2'-deoxyuridine and leucovorin.

Anti-cancer drugs·2001
Same author

A new steroidal alkaloid from the roots of Cynanchum caudatum.

Planta medica·2000
Same author

Mutagenicity studies of methyl-tert-butylether using the Ames tester strain TA102.

Mutation research·1999

Area of Science:

  • Medicinal Chemistry
  • Organic Chemistry
  • Pharmacology

Background:

  • Organoselenium compounds are explored as potential alkylating agents for cancer therapy.
  • Understanding the structure-activity relationship of these compounds is crucial for drug design.
  • Comparing selenium and sulfur analogs provides insights into nucleophilicity and reactivity.

Purpose of the Study:

  • To synthesize and evaluate organoselenium alkylating agents.
  • To compare the chemical reactivity and cytotoxicity of selenium-based agents with their sulfur counterparts.
  • To investigate the impact of structural modifications on alkylating reactivity and biological activity.

Main Methods:

  • Synthesis of organoselenium compounds using selenocyanate intermediates.

Related Experiment Videos

  • Assessment of chemical reactivity via reaction with 4-(4-nitrobenzyl)pyridine (NBP).
  • Evaluation of cytotoxicity against various cancer cell lines (CCRF-CEM, L1210/0, L1210/L-PAM).

    • Main Results:

    • Selenium exhibited significantly higher nucleophilicity than sulfur (2+ orders of magnitude).
    • Alkylating reactivity decreased with increasing chain length (ethylene vs. propylene).
    • Structural modifications, like replacing chloride with mesylate, restored reactivity and cytotoxicity.

    Conclusions:

    • The inherent reactivity of selenium is a key factor in designing effective antitumor organoselenides.
    • 3-chloro-n-propyl selenides are insufficiently reactive for biological alkylation.
    • Optimized organoselenium structures can achieve desirable reactivity and potent cytotoxicity.